{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:05:18Z","timestamp":1761807918908},"reference-count":6,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1136\/jnnp-2014-310127","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T03:46:00Z","timestamp":1422503160000},"page":"705-705","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Rethinking of doxycycline therapy in Creutzfeldt-Jakob disease"],"prefix":"10.1136","volume":"86","author":[{"given":"Maurizio","family":"Pocchiari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ladogana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"key":"key-10.1136\/jnnp-2014-310127-1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Ha\u00efk","year":"2014","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2014-310127-2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/jnnp-2014-309871","article-title":"A case of variably protease-sensitive prionopathy treated with doxycyclin","volume":"86","author":"Assar","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2014-310127-3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.22094","article-title":"Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein","volume":"68","author":"Zou","year":"2010","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2014-310127-4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871526510909010023","article-title":"Tetracyclines and prion infectivity","volume":"9","author":"Forloni","year":"2009","journal-title":"Infect Disord Drug Targets"},{"key":"key-10.1136\/jnnp-2014-310127-5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/21678707.2015.994605","article-title":"The future for treating Creutzfeldt\u2013Jakob disease","volume":"3","author":"Vetrugno","year":"2015","journal-title":"Expert Opin Orphan Drugs"},{"key":"key-10.1136\/jnnp-2014-310127-6","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2174\/15680266113136660173","article-title":"Therapy in prion diseases","volume":"13","author":"Forloni","year":"2013","journal-title":"Curr Top Med Chem"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2014-310127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:00:24Z","timestamp":1601056824000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2014-310127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":6,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,6,12]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1136\/jnnp-2014-310127"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2014-310127","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,28]]}}}